These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 4727832)
21. Hepatotoxicity of methotrexate in the treatment of psoriasis. Roenigk HH; Bergfeld WF; St Jacques R; Owens FJ; Hawk WA Arch Dermatol; 1971 Mar; 103(3):250-61. PubMed ID: 5548272 [No Abstract] [Full Text] [Related]
22. Analysis of risk factors in psoriatic patients with methotrexate-induced increases in transaminase levels. Heydendael VM; Spuls PI; Bossuyt PM; Bos JD; de Rie MA Arch Dermatol; 2004 Oct; 140(10):1289-90. PubMed ID: 15492205 [No Abstract] [Full Text] [Related]
23. [Liver damage in methotrexate-treated patients. When liver biopsy is necessary in the follow-up?]. Nieminen U; Höök-Nikanne J; Kärkkäinen P; Niemelä S Duodecim; 2005; 121(24):2680-8. PubMed ID: 16454249 [No Abstract] [Full Text] [Related]
24. [Apropos of 2 accidents during general treatments with methotrexate]. Amblard P; Dugois P; Imbert R; Fillon JP; Martel J Bull Soc Fr Dermatol Syphiligr; 1971; 78(1):85-7. PubMed ID: 5565944 [No Abstract] [Full Text] [Related]
25. Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens. Dahl MG; Gregory MM; Scheuer PJ Br Med J; 1972 Mar; 1(5801):654-6. PubMed ID: 5015292 [TBL] [Abstract][Full Text] [Related]
33. A prospective study of the effects of weekly oral methotrexate on liver biopsy. Warin AP; Landells JW; Levene GM; Baker H Br J Dermatol; 1975 Sep; 93(3):321-7. PubMed ID: 1103936 [TBL] [Abstract][Full Text] [Related]
35. Predictive value of HLA antigen for methotrexate-induced liver damage in patients with psoriasis. Pestana A; Halprin KM; Taylor JR; Schiff ER; Esquenazi V; Comerford M; Gomez C J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):26-9. PubMed ID: 3980800 [TBL] [Abstract][Full Text] [Related]
36. Liver disease in psoriatics--An effect of methotrexate therapy? Shapiro HA; Trowbridge JO; Lee JC; Maibach HI Arch Dermatol; 1974 Oct; 110(4):547-51. PubMed ID: 4414499 [No Abstract] [Full Text] [Related]
37. Daily practice assessment of liver injury in patients with psoriasis on methotrexate. Driessen RJ; van de Kerkhof PC; de Jong EM Br J Dermatol; 2010 Jan; 162(1):211-3. PubMed ID: 19903179 [No Abstract] [Full Text] [Related]
38. Liver biopsies from psoriatics treated with methotrexate. Ho MS; Cheah E; Tham SN; Teh LB; Ng HS; Thirumoorthy S Ann Acad Med Singap; 1986 Apr; 15(2):210-4. PubMed ID: 3752896 [TBL] [Abstract][Full Text] [Related]
39. Azaribine therapy for psoriasis. Evaluation of potential effects on the liver and other organ systems. Keefer RA; Roenigk HH; Hawk WA Arch Dermatol; 1975 Jul; 111(7):853-6. PubMed ID: 1173747 [TBL] [Abstract][Full Text] [Related]
40. Liver biopsies in psoriatics--complications and evaluation. Creswell SN; Burrows D Int J Dermatol; 1980 May; 19(4):217-9. PubMed ID: 7399795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]